Pharma Industry News Weekly Recap: May 26, 2023
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
// Biotech and Pharma Therapeutics Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program May [...]
// Biotech and Pharma Therapeutics Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal May [...]
// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA [...]
// Biotech and Pharma Therapeutics 'Lots of ways for donanemab to win' in Alzheimer's, Lilly says. Now, it just [...]
// Biotech and Pharma Therapeutics Tubulis and BMS Team Up to Develop Antibody-Drug Conjugates for Cancer April 21, [...]
// Biotech and Pharma Therapeutics Prothena raids pharmacy aisle for Alzheimer's trial accelerant, teaming with Walgreens April 13, [...]
// Biotech and Pharma Therapeutics VBI Vaccines pares down pipeline and staff to focus on hepatitis B programs [...]
// Biotech and Pharma Therapeutics AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning [...]
// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label [...]